Stem Cell Therapy Unit - Institute for Respiratory Health

Stem Cell Therapy Unit


Established in 2011, the Unit is led by Associate Professor Yuben Moodley. The Unit investigates the potential of stem cells as a therapy for lung diseases. Research is currently focused on chronic obstructive pulmonary disease, pulmonary fibrosis, asthma and cystic fibrosis.

The research focus for the Unit centres on:

  • Molecular mechanism of chronic inflammation
  • Identifying biomarkers for lung diseases
  • Cell therapies for lung disease
  • Inflammation in Chronic Obstructive Pulmonary Disease
  • Immunological and molecular mechanisms underlying chronic airway diseases
  • Host immune defences against bacterial and viral pathogens.

Current research projects

  • Protective Anti-Bacterial Responses
  • T-cell Co-inhibitory Receptors (PD-1, CTLA-4)
  • IPF Bio-bank.

Unit highlights

The Stem Cell Therapy team have several highlights for 2017/18. These include:

  • Jesse Armitage, PhD Candidate awarded the prestigious Ann Woolcokc New Investigator Award for 2019.
  • CRE-PF CREATE Fellowship Travel Scholarship and the TSANZ ASM Travel Award awarded to Dr Britt Clynick


Our People
The Stem Cell Therapy Unit is a combination of both clinical and laboratory staff and collaborates with peers on a local, national and international level.